These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 38353479)
1. Prostate and gut: Any relationship? A narrative review on the available evidence and putative mechanisms. Romano L; Napolitano L; Crocetto F; Sciorio C; Sio M; Miranda A; Romano M; Priadko K Prostate; 2024 May; 84(6):513-524. PubMed ID: 38353479 [TBL] [Abstract][Full Text] [Related]
2. Gut microbiome: a novel preventive and therapeutic target for prostatic disease. Cao H; Zhang D; Wang P; Wang Y; Shi C; Wu H; Du H; Zhang W; Gou Z; Zhou H; Wang S Front Cell Infect Microbiol; 2024; 14():1431088. PubMed ID: 39135640 [TBL] [Abstract][Full Text] [Related]
5. Abnormal gut microbiota composition is associated with experimental autoimmune prostatitis-induced depressive-like behaviors in mice. Du HX; Liu Y; Zhang LG; Zhan CS; Chen J; Zhang M; Chen XG; Zhang L; Liang CZ Prostate; 2020 Jun; 80(9):663-673. PubMed ID: 32255522 [TBL] [Abstract][Full Text] [Related]
6. Poria cocos polysaccharides attenuate chronic nonbacterial prostatitis by targeting the gut microbiota: Comparative study of Poria cocos polysaccharides and finasteride in treating chronic prostatitis. Liu J; Liu L; Zhang G; Peng X Int J Biol Macromol; 2021 Oct; 189():346-355. PubMed ID: 34428489 [TBL] [Abstract][Full Text] [Related]
7. The role of gut microbiota in prostate inflammation and benign prostatic hyperplasia and its therapeutic implications. Chen J; Chen B; Lin B; Huang Y; Li J; Li J; Chen Z; Wang P; Ran B; Yang J; Huang H; Liu L; Wei Q; Ai J; Cao D Heliyon; 2024 Oct; 10(19):e38302. PubMed ID: 39386817 [TBL] [Abstract][Full Text] [Related]
8. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433 [TBL] [Abstract][Full Text] [Related]
9. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment. Kustrimovic N; Bombelli R; Baci D; Mortara L Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675055 [TBL] [Abstract][Full Text] [Related]
10. Mechanismbased role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. Yan M; Guo X; Ji G; Huang R; Huang D; Li Z; Zhang D; Chen S; Cao R; Yang X; Wu W Front Immunol; 2022; 13():1097853. PubMed ID: 36936475 [TBL] [Abstract][Full Text] [Related]
11. Associations between gut microbiota and three prostate diseases: a bidirectional two-sample Mendelian randomization study. Liu X; Dong Q Sci Rep; 2024 Feb; 14(1):4019. PubMed ID: 38369514 [TBL] [Abstract][Full Text] [Related]
12. Influence of microbiome in intraprostatic inflammation and prostate cancer. Prakash P; Verma S; Gupta S Prostate; 2024 Sep; 84(13):1179-1188. PubMed ID: 38899408 [TBL] [Abstract][Full Text] [Related]
13. Prostate diseases and microbiome in the prostate, gut, and urine. Miyake M; Tatsumi Y; Ohnishi K; Fujii T; Nakai Y; Tanaka N; Fujimoto K Prostate Int; 2022 Jun; 10(2):96-107. PubMed ID: 35510078 [TBL] [Abstract][Full Text] [Related]
14. Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer. He J; Han Z; Luo W; Shen J; Xie F; Liao L; Zou G; Luo X; Guo Z; Li Y; Li J; Chen H Front Immunol; 2022; 13():998447. PubMed ID: 36685547 [TBL] [Abstract][Full Text] [Related]
15. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study. Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357 [TBL] [Abstract][Full Text] [Related]
16. Gut microbiome and prostate cancer. Fujita K; Matsushita M; Banno E; De Velasco MA; Hatano K; Nonomura N; Uemura H Int J Urol; 2022 Aug; 29(8):793-798. PubMed ID: 35388531 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer cells. Han IH; Kim JH; Jang KS; Ryu JS Prostate; 2019 Jul; 79(10):1133-1146. PubMed ID: 31050003 [TBL] [Abstract][Full Text] [Related]
18. Obesity and gut-microbiota-brain axis: A narrative review. Asadi A; Shadab Mehr N; Mohamadi MH; Shokri F; Heidary M; Sadeghifard N; Khoshnood S J Clin Lab Anal; 2022 May; 36(5):e24420. PubMed ID: 35421277 [TBL] [Abstract][Full Text] [Related]
19. The Microbiome and Prostate Cancer Risk. Wheeler KM; Liss MA Curr Urol Rep; 2019 Sep; 20(10):66. PubMed ID: 31493090 [TBL] [Abstract][Full Text] [Related]
20. The microbiome in prostate inflammation and prostate cancer. Porter CM; Shrestha E; Peiffer LB; Sfanos KS Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):345-354. PubMed ID: 29795140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]